191 related articles for article (PubMed ID: 34946593)
1. High-Throughput Screening Campaign Identified a Potential Small Molecule RXFP3/4 Agonist.
Lin G; Feng Y; Cai X; Zhou C; Shao L; Chen Y; Chen L; Liu Q; Zhou Q; Bathgate RAD; Yang D; Wang MW
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946593
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a small molecule RXFP3/4 agonist that increases food intake in rats upon acute central administration.
DeChristopher B; Park SH; Vong L; Bamford D; Cho HH; Duvadie R; Fedolak A; Hogan C; Honda T; Pandey P; Rozhitskaya O; Su L; Tomlinson E; Wallace I
Bioorg Med Chem Lett; 2019 Apr; 29(8):991-994. PubMed ID: 30824200
[TBL] [Abstract][Full Text] [Related]
3. High-throughput screening campaign identifies a small molecule agonist of the relaxin family peptide receptor 4.
Lin GY; Lin L; Cai XQ; Dai AT; Zhu Y; Li J; Liu Q; Yang DH; Bathgate RAD; Wang MW
Acta Pharmacol Sin; 2020 Oct; 41(10):1328-1336. PubMed ID: 32235863
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and pharmacological evaluation of tricyclic derivatives as selective RXFP4 agonists.
Lin L; Lin G; Zhou Q; Bathgate RAD; Gong GQ; Yang D; Liu Q; Wang MW
Bioorg Chem; 2021 May; 110():104782. PubMed ID: 33730669
[TBL] [Abstract][Full Text] [Related]
5. Discovery and Characterization of the First Nonpeptide Antagonists for the Relaxin-3/RXFP3 System.
Gay EA; Guan D; Van Voorhies K; Vasukuttan V; Mathews KM; Besheer J; Jin C
J Med Chem; 2022 Jun; 65(11):7959-7974. PubMed ID: 35594150
[TBL] [Abstract][Full Text] [Related]
6. Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135).
Zhu J; Kuei C; Sutton S; Kamme F; Yu J; Bonaventure P; Atack J; Lovenberg TW; Liu C
Eur J Pharmacol; 2008 Aug; 590(1-3):43-52. PubMed ID: 18582868
[TBL] [Abstract][Full Text] [Related]
7. Development of a selective agonist for relaxin family peptide receptor 3.
Wei D; Hu MJ; Shao XX; Wang JH; Nie WH; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2017 Jun; 7(1):3230. PubMed ID: 28607363
[TBL] [Abstract][Full Text] [Related]
8. Indole-Containing Amidinohydrazones as Nonpeptide, Dual RXFP3/4 Agonists: Synthesis, Structure-Activity Relationship, and Molecular Modeling Studies.
Guan D; Rahman MT; Gay EA; Vasukuttan V; Mathews KM; Decker AM; Williams AH; Zhan CG; Jin C
J Med Chem; 2021 Dec; 64(24):17866-17886. PubMed ID: 34855388
[TBL] [Abstract][Full Text] [Related]
9. Targeting the relaxin-3/RXFP3 system: a patent review for the last two decades.
Rahman MT; Chaminda Lakmal HH; Hussain J; Jin C
Expert Opin Ther Pat; 2024; 34(1-2):71-81. PubMed ID: 38573177
[TBL] [Abstract][Full Text] [Related]
10. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
[TBL] [Abstract][Full Text] [Related]
11. Identification of small-molecule agonists of human relaxin family receptor 1 (RXFP1) by using a homogenous cell-based cAMP assay.
Chen CZ; Southall N; Xiao J; Marugan JJ; Ferrer M; Hu X; Jones RE; Feng S; Agoulnik IU; Zheng W; Agoulnik AI
J Biomol Screen; 2013 Jul; 18(6):670-7. PubMed ID: 23212924
[TBL] [Abstract][Full Text] [Related]
12. Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays.
Wu H; Hoare BL; Handley TNG; Akhter Hossain M; Bathgate RAD
Biochem Pharmacol; 2024 Jun; 224():116238. PubMed ID: 38677442
[TBL] [Abstract][Full Text] [Related]
13. Partial agonist activity of R3(BΔ23-27)R/I5 at RXFP3--investigation of in vivo and in vitro pharmacology.
Kristensson L; Mayer G; Ploj K; Wetterlund M; Arlbrandt S; Björquist A; Wissing BM; Castaldo M; Larsson N
Eur J Pharmacol; 2015 Jan; 747():123-31. PubMed ID: 25496752
[TBL] [Abstract][Full Text] [Related]
14. Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1.
Shabanpoor F; Akhter Hossain M; Ryan PJ; Belgi A; Layfield S; Kocan M; Zhang S; Samuel CS; Gundlach AL; Bathgate RA; Separovic F; Wade JD
J Med Chem; 2012 Feb; 55(4):1671-81. PubMed ID: 22257012
[TBL] [Abstract][Full Text] [Related]
15. Mechanism for insulin-like peptide 5 distinguishing the homologous relaxin family peptide receptor 3 and 4.
Hu MJ; Shao XX; Wang JH; Wei D; Guo YQ; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2016 Jul; 6():29648. PubMed ID: 27404393
[TBL] [Abstract][Full Text] [Related]
16. Central relaxin-3 receptor (RXFP3) activation decreases anxiety- and depressive-like behaviours in the rat.
Ryan PJ; Büchler E; Shabanpoor F; Hossain MA; Wade JD; Lawrence AJ; Gundlach AL
Behav Brain Res; 2013 May; 244():142-51. PubMed ID: 23380674
[TBL] [Abstract][Full Text] [Related]
17. International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.
Halls ML; Bathgate RA; Sutton SW; Dschietzig TB; Summers RJ
Pharmacol Rev; 2015; 67(2):389-440. PubMed ID: 25761609
[TBL] [Abstract][Full Text] [Related]
18. Chronic activation of the relaxin-3 receptor on GABA neurons in rat ventral hippocampus promotes anxiety and social avoidance.
Rytova V; Ganella DE; Hawkes D; Bathgate RAD; Ma S; Gundlach AL
Hippocampus; 2019 Oct; 29(10):905-920. PubMed ID: 30891856
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of relaxin-3 and a selective relaxin-3 receptor agonist on food and water intake and hypothalamic neuronal activity in rats.
de Ávila C; Chometton S; Lenglos C; Calvez J; Gundlach AL; Timofeeva E
Behav Brain Res; 2018 Jan; 336():135-144. PubMed ID: 28864207
[TBL] [Abstract][Full Text] [Related]
20. In vitro pharmacological characterization of RXFP3 allosterism: an example of probe dependency.
Alvarez-Jaimes L; Sutton SW; Nepomuceno D; Motley ST; Cik M; Stocking E; Shoblock J; Bonaventure P
PLoS One; 2012; 7(2):e30792. PubMed ID: 22347403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
